Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple MyelomaJesús F. San Miguel, Hermann Einsele, Andrew Spencer et al.|New England Journal of Medicine|2023Cited by 719
Production, safety and efficacy of iPSC-derived mesenchymal stromal cells in acute steroid-resistant graft versus host disease: a phase I, multicenter, open-label, dose-escalation studyAdrian Bloor, Amit Patel, James E. Griffin et al.|Nature Medicine|2020Cited by 289